| SC 13G/A | 2017-02-14 | Visium Asset Management, LP | CymaBay Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2017-02-09 | ADAGE CAPITAL PARTNERS GP, L.L.C. | CymaBay Therapeutics, Inc. | 1,840,044 | 6.4% | EDGAR |
| SC 13G | 2016-04-20 | Abingworth LLP | CymaBay Therapeutics, Inc. | 1,600,000 | 6.8% | EDGAR |
| SC 13G/A | 2016-02-16 | Point72 Asset Management, L.P. | CymaBay Therapeutics, Inc. | 1,035,288 | 4.4% | EDGAR |
| SC 13G/A | 2016-02-16 | ADAGE CAPITAL PARTNERS GP LLC | CymaBay Therapeutics, Inc. | 1,700,000 | 7.2% | EDGAR |
| SC 13G/A | 2016-02-16 | Lombard Odier Asset Management (USA) Corp | CymaBay Therapeutics, Inc. | 1,085,681 | 4.6% | EDGAR |
| SC 13G/A | 2016-02-12 | Visium Asset Management, LP | CymaBay Therapeutics, Inc. | 321,158 | 1.4% | EDGAR |
| SC 13G/A | 2016-02-12 | ALTA BIOPHARMA PARTNERS III LP | CymaBay Therapeutics, Inc. | 1,001,191 | 4.3% | EDGAR |
| SC 13G/A | 2016-02-10 | Versant Affiliates Fund II-A, LP | CymaBay Therapeutics, Inc. | 20,742 | 0.1% | EDGAR |
| SC 13G/A | 2016-02-08 | PRUDENTIAL FINANCIAL INC | CymaBay Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-03 | JENNISON ASSOCIATES LLC | CymaBay Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2015-02-17 | Point72 Asset Management, L.P. | CymaBay Therapeutics, Inc. | 571,088 | 3.9% | EDGAR |
| SC 13G/A | 2015-02-17 | Versant Affiliates Fund II-A, LP | CymaBay Therapeutics, Inc. | 20,742 | 0.1% | EDGAR |
| SC 13G/A | 2015-02-17 | Flynn James E | CymaBay Therapeutics, Inc. | 80,000 | 0.5% | EDGAR |
| SC 13G | 2015-02-13 | PRUDENTIAL FINANCIAL INC | CymaBay Therapeutics, Inc. | 993,500 | 6.8% | EDGAR |
| SC 13G | 2015-02-12 | ALTA BIOPHARMA PARTNERS III LP | CymaBay Therapeutics, Inc. | 1,029,126 | 7.0% | EDGAR |
| SC 13G | 2015-02-11 | JENNISON ASSOCIATES LLC | CymaBay Therapeutics, Inc. | 993,500 | 6.8% | EDGAR |
| SC 13G | 2015-02-11 | Lombard Odier Asset Management (USA) Corp | CymaBay Therapeutics, Inc. | 1,368,557 | 9.3% | EDGAR |
| SC 13G | 2015-01-29 | Visium Asset Management, LP | CymaBay Therapeutics, Inc. | 1,000,000 | 6.8% | EDGAR |
| SC 13G | 2015-01-23 | ADAGE CAPITAL PARTNERS GP LLC | CymaBay Therapeutics, Inc. | 1,000,000 | 6.8% | EDGAR |